P. Michael Grossman et al. JCIN 2009;2:

Slides:

Advertisements

Similar presentations

Date of download: 6/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Early and long-term clinical outcomes associated.

Advertisements

Date of download: 6/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: Percutaneous Coronary Intervention Complications.

From: Contemporary Mortality Risk Prediction for Percutaneous Coronary Intervention: Results From 588,398 Procedures in the National Cardiovascular Data.

From: Contemporary Mortality Risk Prediction for Percutaneous Coronary Intervention: Results From 588,398 Procedures in the National Cardiovascular Data.

Changing trends in incidence and predictors of radiographic contrast nephropathy after percutaneous coronary intervention with use of fenoldopam Annapoorna.

IABP-SHOCK II Score Stratifies Patient Risk in CS after AMI

Successful CTO PCI Associated with Lower Mortality Risk

Mortality Related to Periprocedural MI in CTO-PCI

Stephen W. Waldo et al. JACC 2008;51:

Adjusted odds ratio 95% CI Diagnostic angiography PCI CABG

Acute Kidney Injury and In-Hospital Mortality after Coronary Artery Bypass Graft versus Percutaneous Coronary Intervention: A Nationwide Study Shen et.

Glenn N. Levine et al. JACC 2016;68:

Kenshi Hayashi et al. JACEP 2016;2:

Belinda Gray et al. JCHF 2013;1:

Ryoji Nagoshi et al. JCIN 2016;9:e107-e109

Wesley T. O’Neal et al. JACEP 2016;2:

Gregory Piazza et al. JCIN 2015;8:

Mohit K. Turagam et al. JACEP 2017;3:

Miralem Pasic et al. JCIN 2015;8:1-9

Risk Stratification and Interventional Cardiology: Robert L

Kaplan-Meier curves: revascularisation rate (PCI or CABG) was significantly higher (p

Ashraf Hamdan et al. JCIN 2015;8:

Mintu P. Turakhia et al. JACEP 2016;2:

Prakash Harikrishnan et al. JACEP 2015;1:

K.R. Julian Chun et al. JACEP 2017;3:

(A) Illustration of the receiver operating characteristic (ROC) curve (discrimination) of the recalibrated model on the external validation set data. (A)

Deepali Nivas Tukaye et al. JCIN 2016;j.jcin

Prabhat Kumar et al. JACEP 2016;j.jacep

Yoshitaka Kimura et al. JACEP 2016;2:

Vittorio Calzolari et al. JACEP 2017;3:

Kenshi Hayashi et al. JACEP 2016;2:

Kaplan-Meier estimate of mortality in 1798 propensity score matched pairs with a propensity score >0.5 for the whole observational period. Kaplan-Meier.

Takumi Higuma et al. JCIN 2016;9:

Mintu P. Turakhia et al. JACEP 2016;2:

Nat. Rev. Cardiol. doi: /nrcardio

Yusuke Watanabe et al. JCIN 2016;9:

Bernard Lim et al. JACEP 2016;2:

John Rickard et al. JCHF 2013;1:

Jamil Aboulhosn et al. JCIN 2017;10:53-63

(A) Multivariable Cox regressions showing the association of higher CHA2DS2-Vasc scores (≥6) and (B) R2CHA2DS2-Vasc scores (≥7) with 1-year mortality (CABG,

Cox regression of proportion mortality in the first 8 years for patients with three-vessel disease with a significant difference between the treatment.

Glenn N. Levine et al. JACC 2011;58:e44-e122

Jordan B. King et al. JCHF 2016;4:

Kaplan–Meyer survival curve of 1313 patients following primary PCI

Alfredo R. Galassi et al. JCIN 2016;9:

Alfredo R. Galassi et al. JCIN 2016;9:

Charanjit S. Rihal et al. JCIN 2012;5:

Vasim Farooq et al. JCIN 2013;6:

Davide Capodanno et al. JCIN 2009;2:

Herbert D. Aronow et al. JCIN 2015;8:49-56

Nils P. Johnson et al. JCIN 2015;8:

Saadia Sherazi et al. JACEP 2015;1:74-80

Alfredo R. Galassi et al. JCIN 2016;9:

Maria Alejandra Restrepo-Cordoba et al. JCIN 2016;9:e137-e139

Leslee J. Shaw et al. JIMG 2010;3:

Ryan R. Reeves et al. JCIN 2015;8:

A model of variation and accelerating factors in the process of acute care chain of patients with STEMI going for primary PCI. PCI, percutaneous coronary.

Gregory Piazza et al. JCIN 2015;8:

Davide Capodanno et al. JCIN 2009;2:

The possible off-target effect of increased heart failure hospitalizations from saxagliptin in the SAVOR trial. The possible off-target effect of increased.

Matias B. Yudi et al. JACC 2018;71:

Matias B. Yudi et al. JACC 2018;71:

Kaplan-Meier estimate of mortality in the two treatment strategies with significant difference between the two groups (log-rank test

Orly Vardeny et al. JCHF 2016;4:

Evan M. Zahn et al. JCIN 2016;9: Relationship Between Patent Ductus Arteriosus Closure and Left Ventricular Ejection Fraction The graph depicts.

Michael Reed et al. JCIN 2009;2:

Miralem Pasic et al. JCIN 2015;8:1-9

Stefan Toggweiler et al. JCIN 2016;9:

FFR guided deferral of PCI in patients with ACS and stable coronary artery disease (SCAD). FFR guided deferral of PCI in patients with ACS and stable coronary.

Henry Chubb et al. JACEP 2017;3:89-103

Presentation transcript:

P. Michael Grossman et al. JCIN 2009;2:636-644 Standardized Mortality Rate in Patients Undergoing PCI Based Upon the Guide Catheter Size The observed and predicted mortality of 8-F guide catheter PCI patients was higher than the observed mortality of the 6- and 7-F guide patients (p < 0.05 for both). The observed mortality in patients treated with 8-F guide catheters was higher than the predicted mortality (p < 0.05) and the observed mortality of those who underwent PCI with a 6-F guide was lower than the predicted mortality (p < 0.05). The SMR (a ratio of observed mortality and predicted mortality) of patients treated with an 8-F guide was significantly higher than the SMR of patients who underwent PCI with a 6- or 7-F catheter (p < 0.05). PCI = percutaneous coronary intervention; SMR = standardized mortality rate. P. Michael Grossman et al. JCIN 2009;2:636-644 American College of Cardiology Foundation